Iremofar (Hydroxyzine Hydrochloride)

Hydroxyzine hydrochloride works by selectively blocking peripheral H1 histamine receptors, which reduces allergic symptoms, and by blocking central H1 receptors, which produces sedative and anxiolytic effects. It also has anticholinergic activity that helps control nausea.

The appropriate dose of Iremofar is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for hydroxyzine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To order Iremofar, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Iremofar (hydroxyzine) is a first‑generation antihistamine, which provides both antihistaminic and sedative effects. Compared with second‑generation antihistamines, it may cause more drowsiness but is often preferred when sedation or anxiety relief is also needed.

Iremofar should be stored at room temperature, below 25 °C, in the original packaging. Keep it away from moisture and direct sunlight to maintain product stability.

Iremofar is taken orally as directed by a healthcare professional. It may be swallowed with water, and the dosage form is typically a tablet or capsule, depending on the specific product presentation.

Serious risks include severe allergic reactions such as anaphylaxis, cardiac arrhythmias, and seizures. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, irregular heartbeat, or convulsions.

Iremofar should be avoided in individuals with known hypersensitivity to hydroxyzine or any component of the formulation, in patients taking certain CNS depressants without medical supervision, and in those with severe hepatic impairment unless specifically advised by a physician.